QA: Arena Pharmaceuticals INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001080709_2020_Arena_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001080709, Arena Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 759,934,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 25,128,000
3 remainder_Assets 389,061,000
4 LiabilitiesCurrent 44,967,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 119,331,473
9 ResearchAndDevelopmentExpense 460,854,809
10 remainder_Expenses -109,852,855
11 remainder_Revenues 518,358,143
12 remainder_NetIncome 23,444,369
13 remainder_ComprehensiveNetIncome 1,292,326
  yvar yval
0 Assets 1,174,123,000
1 Liabilities 44,967,000
2 Expenses 470,333,427
3 Revenues 518,358,143
4 StockholdersEquity 1,129,156,000
5 NetIncome 71,469,085
6 ComprehensiveNetIncome 72,115,248
7 BaseVar 1,116,259,132
8 EconomicCapitalRatiobeforeLimitedLiability 4.16
9 EconomicCapitalRatio 4.51

Edgar->Model Mapping

Feature Distribution

Change over Time